CHCHD2 and Parkinson's disease-Authors' reply

The Lancet Neurology

Volumn 14, Issue 7, 2015, Pages 682-683

  Funayama, Manabu ^a,b   Hattori, Nobutaka ^a,b  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; TAR DNA BINDING PROTEIN; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR;

AUTOSOMAL DOMINANT INHERITANCE; BRAIN MITOCHONDRION; CAUSAL ATTRIBUTION; CHCHD2 GENE; ESSENTIAL TREMOR; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LETTER; META ANALYSIS (TOPIC); MUTATOR GENE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; DNA SEQUENCE; FEMALE; GENETIC LINKAGE; GENETICS; MALE; MISSENSE MUTATION; PARKINSONISM; PROCEDURES;

FEMALE; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; PARKINSONIAN DISORDERS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84930510134     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00097-6     Document Type: Letter

References (6)

1. Funayama M, Ohe K, Amo T, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol 2015, 14:274-282.
2. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.
3. Feyeux M, Bourgois-Rocha F, Redfern A, et al. Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Hum Mol Genet 2012, 21:3883-3895.
4. Song R, Yang B, Gao X, et al. Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma. Mol Med Rep 2015, 11:4053-4062.
5. Kumari U, Tan EK LRRK2 in Parkinson's disease: genetic and clinical studies from patients. FEBS J 2009, 276:6455-6463.
6. Singleton AB, Farrer MJ, Bonifati V The genetics of Parkinson's disease: Progress and therapeutic implications. Mov Disord 2013, 28:14-23.